Same Dog, New Tricks: How Be The Match BioTherapies is Transforming Cellular Therapy in Transplant Centers

Be The Match BioTherapies®—what's that? In this session, learn how the National Marrow Donor Program® (NMDP)/Be The Match® is supporting cell therapy in transplant centers today and into the future.

By the end of this session, you will:

  • Uncover exciting developments in the cell and gene therapy field and how that will impact transplant centers
  • Learn how the NMDP/Be The Match is extending its expertise to support clinical trials in transplant centers and across the cell and gene therapy industry
  • Identify how the NMDP/Be The Match can help advocate for your teams as more cell therapies move into the clinic and become commercially available
  • Review challenges and opportunities in onboarding and working on clinical trials in transplant centers


  • Joy Aho, PhD, Serior Product Manager, NMDP/Be The Match
  • Jeffery Auletta, MD, SVP, Patient Outcomes & Experience, NMDP/Be The Match & Chief Scientific Director, CIBMTR® (Center for International Blood and Marrow Transplant Research®)
  • Makensie Becker, Client Success Manager, Be The Match BioTherapies
  • Eric Davis, MPH, CHTC, Program Manager, BMT Unrelated Donor Search Program, Memorial Sloan Kettering
  • Jamey Hardesty, MPH, Clinical Operations Partner, NMDP/Be The Match

Learn how the NMDP/Be The Match is supporting the developing of next-generation cell and gene therapies through Be The Match BioTherapies.